Log in
NYSE:NVS

Novartis SEC Filings & 10K Form

$90.94
-0.03 (-0.03 %)
(As of 09/18/2020 09:21 PM ET)
Add
Compare
Today's Range
$90.30
Now: $90.94
$91.86
50-Day Range
$82.14
MA: $85.92
$91.00
52-Week Range
$69.18
Now: $90.94
$99.84
Volume2.28 million shs
Average Volume2.17 million shs
Market Capitalization$208.13 billion
P/E Ratio28.96
Dividend Yield2.21%
Beta0.45

SEC Filings

Novartis (NYSE:NVS) SEC Filings

DateFilerForm TypeView
09/01/2020
5:05 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/20/2020
1:21 PM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/19/2020
3:31 PM
Novartis (Filed by)
XOMA Corp (Subject)
Form SC 13G/A
08/17/2020
1:15 PM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2020
3:32 PM
Cellular Biomedicine Group, Inc. (Issuer)
Novartis (Reporting)
NOVARTIS PHARMA AG (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/21/2020
8:38 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/16/2020
3:53 PM
Novartis (Reporting)
NOVARTIS PHARMA AG (Reporting)
Poseida Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/13/2020
5:02 AM
Novartis (Reporting)
NOVARTIS PHARMA AG (Reporting)
Poseida Therapeutics, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/02/2020
6:44 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/25/2020
6:15 PM
Akouos, Inc. (Issuer)
Akouos, Inc. (Issuer)
Novartis (Reporting)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/25/2020
2:17 PM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/18/2020
8:16 PM
Forma Therapeutics Holdings, Inc., (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/17/2020
4:47 PM
Galera Therapeutics, Inc. (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
7:56 PM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/12/2020
5:33 PM
Galera Therapeutics, Inc. (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2020
7:02 PM
Galera Therapeutics, Inc. (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2020
4:36 PM
Galera Therapeutics, Inc. (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2020
7:53 AM
Novartis (Filer)
Form SD
Specialized Disclosure Report  
05/12/2020
5:05 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/28/2020
6:58 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/02/2020
6:50 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2020
9:15 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2020
9:15 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/19/2020
5:05 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/28/2020
7:29 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/12/2020
2:34 PM
Novartis (Filer)
Novartis Capital CORP (Filer)
Form 424B5
02/11/2020
6:57 AM
Novartis (Filer)
Novartis Capital CORP (Filer)
Form 424B5
01/31/2020
5:05 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/30/2020
9:40 AM
Novartis (Filer)
Novartis Capital CORP (Filer)
Form F-3ASR
01/29/2020
8:13 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/29/2020
8:07 AM
Novartis (Filer)
Form IRANNOTICE
01/29/2020
7:51 AM
Novartis (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
01/06/2020
5:29 AM
MEDICINES CO /DE (Subject)
Novartis (Filed by)
Form SC TO-T/A
01/06/2020
5:10 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/23/2019
7:01 AM
MEDICINES CO /DE (Subject)
Novartis (Filed by)
Form SC TO-T/A
12/19/2019
7:02 AM
MEDICINES CO /DE (Subject)
Novartis (Filed by)
Form SC TO-T/A
12/16/2019
5:10 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/05/2019
6:58 AM
MEDICINES CO /DE (Subject)
Novartis (Filed by)
Form SC TO-T
12/05/2019
5:20 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/25/2019
3:52 PM
MEDICINES CO /DE (Subject)
Novartis (Filed by)
Form SC TO-C
11/25/2019
6:32 AM
MEDICINES CO /DE (Subject)
Novartis (Filed by)
Form SC TO-C
11/25/2019
5:30 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/15/2019
4:03 PM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/12/2019
3:15 PM
Galera Therapeutics, Inc. (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2019
4:23 PM
Galera Therapeutics, Inc. (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/01/2019
5:05 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/30/2019
5:05 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/22/2019
7:08 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/08/2019
5:05 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/02/2019
5:05 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/30/2019
5:30 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/17/2019
5:05 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/30/2019
5:05 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/29/2019
5:05 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/18/2019
8:41 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/01/2019
1:20 PM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/07/2019
6:21 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/31/2019
9:00 AM
Novartis (Filer)
Form SD
Specialized Disclosure Report  
05/30/2019
8:27 PM
BICYCLE THERAPEUTICS plc (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2019
5:05 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/24/2019
1:35 PM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/24/2019
1:23 PM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/22/2019
8:43 PM
BICYCLE THERAPEUTICS Ltd (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/09/2019
5:06 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2019
4:23 PM
Aerpio Pharmaceuticals, Inc. (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2019
6:03 PM
Aerpio Pharmaceuticals, Inc. (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2019
12:09 PM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/15/2019
8:26 PM
Aerpio Pharmaceuticals, Inc. (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2019
5:26 PM
Aerpio Pharmaceuticals, Inc. (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2019
4:14 PM
Aerpio Pharmaceuticals, Inc. (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2019
7:23 PM
AILERON THERAPEUTICS INC (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2019
7:09 PM
Aerpio Pharmaceuticals, Inc. (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2019
4:16 PM
Aerpio Pharmaceuticals, Inc. (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2019
5:05 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/22/2019
7:20 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/15/2019
4:25 PM
AILERON THERAPEUTICS INC (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2019
6:56 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/26/2019
5:00 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2019
3:02 PM
Intellia Therapeutics, Inc. (Issuer)
Novartis (Reporting)
Novartis Institutes for BioMedical Research, Inc. (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
01/30/2019
7:09 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/30/2019
6:31 AM
Novartis (Filer)
Form IRANNOTICE
01/30/2019
6:31 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/30/2019
6:19 AM
Novartis (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
12/21/2018
9:04 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/20/2018
11:41 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/06/2018
4:00 PM
ENDOCYTE INC (Subject)
Novartis (Filed by)
Form DFAN14A
11/05/2018
3:49 PM
ENDOCYTE INC (Subject)
Novartis (Filed by)
Form DFAN14A
10/18/2018
4:17 PM
ENDOCYTE INC (Subject)
Novartis (Filed by)
Form DFAN14A
10/18/2018
4:01 PM
ENDOCYTE INC (Subject)
Novartis (Filed by)
Form DFAN14A
10/18/2018
4:00 PM
ENDOCYTE INC (Subject)
Novartis (Filed by)
Form DFAN14A
10/18/2018
4:00 PM
ENDOCYTE INC (Subject)
Novartis (Filed by)
Form DFAN14A
10/18/2018
10:42 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/18/2018
5:05 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/04/2018
3:06 PM
Altimmune, Inc. (Issuer)
Altimmune, Inc. (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2018
8:14 AM
Altimmune, Inc. (Issuer)
Altimmune, Inc. (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2018
6:01 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/29/2018
7:13 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/23/2018
10:01 AM
Novartis (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/22/2018
3:34 PM
AILERON THERAPEUTICS INC (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2018
3:07 PM
Aerpio Pharmaceuticals, Inc. (Issuer)
Novartis (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 9/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.